Article
A non-canonical EZH2 function sensitizes solid tumors to genotoxic stress
2020-09-11
Abstract excerpt
<h4>Summary</h4> Drugs that block the activity of the methyltransferase EZH2 are in clinical development for the treatment of non-Hodgkin lymphomas harboring gain-of-function EZH2 mutations that enhance its polycomb repressive function. In contrast, in castration-resistant prostate cancer (CRPC) we have previously reported that EZH2 plays a non-canonical role as a transcriptional activator. In this setting, we no...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 51bc5778-54a9-5888-80c9-fadadbc4c2a8
- DOI
- 10.1101/2020.09.11.291534
